Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Full Scan Enhanced Dynamic Range MS Improves Metabolite Coverage and Cancer Cell Line Discrimination in Untargeted Metabolomics.

Created on 18 Nov 2026

Authors

Demi J Rijlaarsdam, Michał Kaczmarek, Christian Klaas, Christian Thöing, Kyle L Fort, Susan S Bird, Celia R Berkers, Esther A Zaal

Published in

Analytical chemistry. Volume 98. Issue 45. Pages 32445-32454. Nov 17, 2026.

Abstract

Metabolite detection with mass spectrometry (MS) in untargeted metabolomics is limited by the wide concentration range of metabolites, where high-abundance ions can restrict the detection of low-abundance features. Full Scan enhanced Dynamic Range (eDR) MS addresses this limitation by partitioning the MS1 mass range into multiple subscans and mass windows, reducing ion competition during accumulation. Here, we systematically evaluated different eDR acquisition strategies for untargeted metabolomics. Across four hepatocellular carcinoma cell lines, Full Scan eDR MS increased detectable compounds up to ∼3.5-fold compared with Full Scan MS and improved signal-to-noise ratios of low-abundance compounds. Among equidistant configurations, 12 windows yielded the highest compound count, while custom window distributions enabled targeted enhancement of selected mass regions. In particular, allocating narrower windows to the low-m/z region selectively increased the detection of low-mass compounds. Increased MS1 coverage also translated into deeper MS2 coverage and increased metabolite identifications. This expanded coverage included cancer-relevant metabolites and improved the detection of metabolic differences between cancer cell lines. Overall, Full Scan eDR MS provides a flexible strategy to increase analytical depth in untargeted metabolomics while maintaining data quality. Customization of window size and distribution enables targeted expansion of the dynamic range within predefined mass regions, allowing MS acquisition to be tailored to sample composition and metabolites of interest.

PMID:
43046449
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement